Table 1.
Characteristics of the participants and number of subjects providing information. Values are means (SD) unless indicated otherwise
| Cases
|
Controls
|
||||
|---|---|---|---|---|---|
| Characteristic | No (%) responding | Mean (SD) | No (%) responding | Mean (SD) | |
| Age (years) | 1327 | 72.5 (6.8) | 3262 | 70.5 (7.7) | |
| Age at menopause (years) | 1327 | 50.0 (4.4) | 3262 | 49.8 (4.2) | |
| Age at menarche (years) | 948 | 13.8 (1.5) | 2618 | 13.6 (1.5) | |
| Weight (kg) | 1308 | 61.0 (11.1) | 3233 | 66.8 (11.8) | |
| Height (m) | 1307 | 1.64 (0.07) | 3235 | 1.63 (0.06) | |
| Body mass index (kg/m2) | 1294 | 22.2 (3.8) | 3216 | 24.6 (4.2) | |
| No (%) ever used postmenopausal oestrogen* | 371 (28) | 1189 (36.5) | |||
| Mean duration of use of hormone replacement therapy among ever users (months): | |||||
| Any† | 120 (9.0) | 60.5 (73.3) | 456 (14.0) | 67.5 (79.9) | |
| Without progestins | 81 (6.1) | 60.8 (65.8) | 229 (7.0) | 64.9 (84.0) | |
| With progestins | 56 (4.2) | 43.6 (52.7) | 274 (8.4) | 59.0 (66.1) | |
| With progesterone-like progestins | 14 (1.1) | 38.5 (33.9) | 94 (2.9) | 78.0 (73.1) | |
| With testosterone-like progestins | 45 (3.4) | 50.0 (58.0) | 222 (6.8) | 56.0 (59.7) | |
| With cyclic progestins | 38 (2.3) | 46.9 (47.7) | 167 (5.1) | 70.0 (70.1) | |
| With continuous progestins | 23 (1.7) | 45.7 (60.3) | 138 (4.2) | 64.3 (61.2) | |
*
Including oral or local treatment with oestriol or unspecified oestrogens.
†
Medium potency oestrogens such as oestradiol compounds or conjugated oestrogens.